Time to re-evaluate combination antifungal therapy for invasive aspergillosis and other invasive mycoses
Tom Harrison & Tom Walsh
www.thelancet.com/journals/lan... (paywall) #IDSky #TxID
I would assume this is just the lab reporting the susceptible cephaloprins with “susceptible, increases exposure” without individual testing. EUCAST is recommending this now for Ceftriaxon at least. Cefazolin would be my first choice for MSSA.
As screenshot showing the title of the study "Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study" a and two graphs illustrating the Vaccine effectiveness in the overall cohort and in sub-cohorts.
Out now in @thelancetinfdis.bsky.social our study demonstrates that the MVA-BN (Imvanex/Jynneos) vaccine is safe & effective against mpox, but a single dose does not sufficiently protect people living with #HIV.
Thank you @ema.europa.eu for support
www.thelancet.com/journals/lan...
1/7
Big Change in TB treatment recommendations. 6 months of RIPE (also called RHEZ) was once the only treatment in town for susceptible TB. Now there's an all oral FOUR months of:
Rifapentine
INH
PZA
Moxifloxacin
t.co/8EHiWEhEk8
Skytorial: Piptazo vs Cefepime 😁
Recently this JAMA-IM paper correlating piptazo with mortality has gained a weird amount of attention
(It's been out for months so it's not really new)
This one of the most methodologically horrific papers I've ever seen
Lets talk real quick about the paper...
🔥Everyone's favorite #shorterisbetter table is updated🔥
"BALANCE is now published,
so the table is now updated!
GNB bacteremia is now listed as Bacteremia(non S.aureus)
Neary 5,000 patients have now been randomized to 1 vs. 2 Constantine Units for non S. aureus bacteremia " Dr.Spellberg #idsky
Just to be very clear about things that work.
